Emergence of oseltamivir-resistant pandemic H1N1 virus during prophylaxis.
Baz
Mariana
M
Abed
Yacine
Y
Papenburg
Jesse
J
Bouhy
Xavier
X
Hamelin
Marie-Eve
ME
Boivin
Guy
G
D000293:Adolescent; D000998:Antiviral Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001249:Asthma / Q000150:complications; D018890:Chemoprevention; D004196:Disease Outbreaks; D024882:Drug Resistance, Viral / Q000235:genetics; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D053118:Influenza A Virus, H1N1 Subtype / Q000187:drug effects* / Q000235:genetics / Q000302:isolation & purification; D007251:Influenza, Human / Q000188:drug therapy* / Q000209:etiology / Q000517:prevention & control; D008297:Male; D008826:Microbial Sensitivity Tests; D009154:Mutation; D009439:Neuraminidase / Q000037:antagonists & inhibitors / Q000235:genetics*; D053139:Oseltamivir / Q000494:pharmacology / Q000627:therapeutic use*; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications
D000998:Antiviral Agents; D004791:Enzyme Inhibitors; D053139:Oseltamivir; D009439:Neuraminidase